{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:60953",
      "entity_text" : "capecitabine",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:60838",
      "entity_text" : "irinotecan",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "The formula decreased the incidence of side effects elicited by irinotecan, 5-fluorouracil or leucovorin in colon carcinoma patients and capecitabine in hepatocellular carcinoma patients [XREF_BIBR, XREF_BIBR].",
  "reading_complete" : "2020-08-05T22:20:53Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-05T22:15:34Z",
  "trigger" : "elicited",
  "evidence" : [ "elicited by irinotecan, 5-fluorouracil or leucovorin in colon carcinoma patients and capecitabine" ],
  "pmc_id" : "5425653",
  "score" : 0
}